Put Options

8 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$4.71 - $10.1 $135,648 - $290,880
-28,800 Reduced 5.45%
499,900 $2.79 Million
Q2 2024

Aug 14, 2024

BUY
$7.96 - $13.59 $2.2 Million - $3.75 Million
276,200 Added 109.39%
528,700 $4.45 Million
Q1 2024

May 15, 2024

BUY
$13.56 - $20.78 $999,372 - $1.53 Million
73,700 Added 41.22%
252,500 $3.65 Million
Q4 2023

Feb 14, 2024

BUY
$14.18 - $22.31 $1.63 Million - $2.57 Million
115,000 Added 180.25%
178,800 $3.85 Million
Q3 2023

Nov 14, 2023

BUY
$18.22 - $25.85 $1.16 Million - $1.65 Million
63,800 New
63,800 $1.23 Million
Q4 2019

Feb 13, 2020

SELL
$76.41 - $117.54 $3.44 Million - $5.29 Million
-45,000 Closed
0 $0
Q3 2019

Nov 14, 2019

SELL
$61.52 - $91.1 $1.54 Million - $2.28 Million
-25,000 Reduced 35.71%
45,000 $3.87 Million
Q2 2019

Aug 13, 2019

BUY
$58.04 - $66.99 $4.06 Million - $4.69 Million
70,000 New
70,000 $4.54 Million

Others Institutions Holding NVRO

About NEVRO CORP


  • Ticker NVRO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,387,800
  • Market Cap $144M
  • Description
  • Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...
More about NVRO
Track This Portfolio

Track Caption Management, LLC Portfolio

Follow Caption Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Caption Management, LLC with notifications on news.